| Financial Year |
March 31 2023 |
| Monetary Funds |
259,605,229.76 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
1,227,624,957.21 |
| Advances to Suppliers |
14,815,117.15 |
| Other Receivables |
80,102,447.30 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
240,649,591.07 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,867,026.14 |
| Total Current Assets |
2,301,801,958.55 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
166,284,111.82 |
| Under-construction Projects |
210,619.48 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
41,941,385.33 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
6,155,368.15 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
236,284,452.02 |
| Total Assets |
2,538,086,410.57 |
| Short-Term Loans |
470,177,278.44 |
| Trading Financial liabilities |
-- |
| Notes Payable |
247,193,620.62 |
| Accounts Payable |
498,897,331.80 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
19,803,670.55 |
| Taxes Payable |
15,780,073.97 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
162,312,615.23 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
271,189,690.94 |
| Other Current Liabilities |
1,305,363.84 |
| Sub-Total of Current Liabilities |
1,775,702,218.44 |
| Long-term Loans |
447,884,141.23 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
116,299,353.77 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
564,183,495.00 |
| Total Liabilities |
2,339,885,713.44 |
| Paid-In Capital(Or Share Stock) |
286,000,000.00 |
| Capital Surplus |
610,814,370.17 |
| Surplus Reserve |
42,566,226.78 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-821,026,268.95 |
| Minority Stockholder's Interest |
71,016,800.06 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
127,183,897.07 |
| Owner's Equity（Stockholder's Equity） |
198,200,697.13 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,538,086,410.57 |
